Targeting HER2 in Biliary Tract Carcinomas: Challenges and Opportunities

Oncol Res Treat. 2021;44(1-2):1-3. doi: 10.1159/000513847. Epub 2021 Jan 13.

Authors

Dieter Koeberle¹, Ralph Fritsch²

Affiliations

¹ Department of Medical Oncology and Hematology, University Hospital Zurich, Zurich, Switzerland, [email protected].
² Department of Medical Oncology and Hematology, Claraspital Basel and University of Bern, Bern, Switzerland.

PMID: 33440395
DOI: 10.1159/000513847

No abstract available

Publication types

Editorial

MeSH terms

Biliary Tract Neoplasms* / drug therapy
Biliary Tract*
Carcinoma*
Humans
Receptor, ErbB-2

Substances

Receptor, ErbB-2